Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.5.2 (
NQO1
)
6,196
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Brain tumors are associated with genetic alterations of oncogenes and tumor suppressor genes. Accumulation of reactive oxygen species (ROS) in cells leads to oxidative stress-induced damage, resulting in tumorigenesis. Here, we showed that the nuclear matrix protein nuclear restricted protein in brain (
NRP
/B) was colocalized and interacted with NF-E2-related factor 2 (Nrf2). During oxidative stress response,
NRP
/B expression and its interaction with Nrf2 were upregulated in SH-SY5Y cells. Association of
NRP
/B with Nrf2 was crucial for NAD(P)H:quinone oxidoreductase 1 (
NQO1
) expression.
NRP
/B was localized predominantly in the nucleus of normal brain cells, whereas in primary brain tumors
NRP
/B was almost exclusively contained in the cytoplasm. In addition, unlike wild-type
NRP
/B, the expression of
NRP
/B mutants isolated from primary brain tumors was found in the cytoplasm, and these mutants failed to induce Nrf2-dependent
NQO1
transcription. Thus,
NRP
/B mutations and their altered localization resulted in changes in
NRP
/B function and deregulation of Nrf2-dependent
NQO1
activation in brain tumors. This study provides insights into the mechanism by which the
NRP
/B modulates Nrf2-dependent
NQO1
induction in cellular protection against ROS in brain tumors.
...
PMID:NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors. 1898 88
Reactive molecules have diverse effects on cells and contribute to several pathological conditions. Cells have evolved complex protective systems to neutralize these molecules and restore redox homeostasis. Previously, we showed that association of nuclear factor (NF)-erythroid-derived 2 (E2)-related factor 2 (NRF2) with the nuclear matrix protein NRP/B was essential for the transcriptional activity of NRF2 target genes in tumor cells. The present study demonstrates the molecular mechanism by which
NRP
/B, via NRF2, modulates the transcriptional activity of antioxidant response element (ARE)-driven genes.
NRP
/B is localized in the nucleus of primary brain tissue and human neuroblastoma (SH-SY5Y) cells. Treatment with hydrogen peroxide (H(2)O(2)) enhances the nuclear colocalization of NRF2 and
NRP
/B and induces heme oxygenase 1 (HO1). Treatment of
NRP
/B or NRF2 knockdowns with H(2)O(2) induced apoptosis. Co-expression of NRF2 with members of the Kelch protein family,
NRP
/B, MAYVEN, or MAYVEN-related protein 2 (MRP2), revealed that the NRF2-
NRP
/B complex is important for the transcriptional activity of ARE-driven genes HO1 and NAD(P)H:quinine oxidoreductase 1 (
NQO1
).
NRP
/B interaction with Nrf2 was mapped to NRF2 ECH homology 4 (Neh4)/Neh5 regions of NRF2.
NRP
/B mutations that resulted in low binding affinity to NRF2 were unable to activate NRF2-modulated transcriptional activity of the ARE-driven genes, HO1 and
NQO1
. Thus, the interaction of
NRP
/B with the Neh4/Neh5 domains of NRF2 is indispensable for activation of NRF2-mediated ARE-driven antioxidant and detoxifying genes that confer cellular defense against oxidative stress-induced damage.
...
PMID:Nuclear matrix protein (NRP/B) modulates the nuclear factor (Erythroid-derived 2)-related 2 (NRF2)-dependent oxidative stress response. 2051 Dec 22